Apollo Proton Cancer Centre (APCC) is the first and only proton therapy center in South Asia, the Middle East and Africa.
At the just-ended stakeholder meeting organized by Shinon Healthcare, a Medical and Health Consultancy company based in Singapore with offices across 12 countries over 14 countries, including Ghana representing, the CEO of Apollo Proton Cancer Centre, Mr. Harish Trivedi, illuminated that the purpose of setting up the center is to create access and a fighting chance to win the fight against cancer
Dr. Rakesh Jalali, Medical Director of APCC, explained that Proton therapy is a radiation therapy that uses tiny particles called protons. Protons are excellent cell killers, but because of the way protons deliver their energy, proton therapy does not damage as much healthy tissue as much as photon therapy.
Therefore, a higher radiation dose can target the tumor without affecting many normal healthy cells. The pencil beam technology used in the treatment gives the added advantage of accurately targeting the tumor without damaging the healthy tissues either before or behind the tumor. Proton therapy is at least as effective as conventional radiation therapy but with fewer side effects.
In some cases, proton therapy is not only the best but also the only option. It has been proven successful in curing or controlling many cancers when used appropriately. Success after radiation therapy depends on the type and stage of cancer treated. Control rates with proton therapy can be as high as 85-90% in certain cancers like chordomas, brain tumors, or liver cancers.
Proton therapy has many advantages, including:
- Targets tumors and cancer cells with precision and minimal exit dose.
- Reduces overall toxicity.
- Reduces the probability and/or severity of short- and long-term side effects on surrounding healthy tissues and organs (e.g., reduces the likelihood of secondary tumors caused by treatment).
- Precisely delivers an optimal radiation dose to the tumor.
- It can treat recurrent tumors, even in patients who have already received radiation.
- Improves quality of life during and after treatment.
- Increases the long-term, progression-free survival rates for certain types of tumors.
Among the cancers treated are Bone & Soft Tissue, Breast, Central Nervous System, Gastrointestinal, Gynaecology, Head & Neck, Lymphoma, Paediatrics, Thoracic & Urology. Its robust multi-disciplinary platform at the bedrock of APCC’s approach to treating cancer; highly skilled clinicians come together to form a cancer management team(CMT). Each CMT is focused on delivering the best possible outcomes for their patients with utmost care.
Mr. Christopher Rockson, who represented Ghana at the meeting, enquired about Apollo Hospitals’ plans to support Africa (Ghana) increase its healthcare standards and infrastructure. In response, the founder and Chairman of Apollo Hospitals Group, Dr. Prathap C. Reddy, indicated that there is a special program named APOLLO CONNECT which is aimed at sharing knowledge, creating partnerships and investing in strategic healthcare-related projects in partner countries and that Ghana holds a special place in his heart as India and Ghana share a long-standing history of cooperation.
On his part, Mr. Rockson mentioned that a cooperation agreement has already been signed with Shinon Healthcare to set up an information center focusing on the West African market and hoped this would lead to fast-tracking Apollo’s plans to establish a physical presence in Ghana.